Royalty Pharma | 44.65 +0.55 +1.25% | ||
| RPRX | |||
| 高 44.92 | 开 44.31 | 量 353.52万股 | 总市值 257.74亿 |
| 低 43.95 | 换 0.61% | 额 1.58亿 | 市盈TTM 33.69 |
分时
5日
日K
周K
月K
季K
年K
OYang
01-12 09:24
#药闻简讯# $梯瓦制药(TEVA)$
与 $Royalty Pharma(RPRX)$ 达成价值 5 亿美元的协议，用于 TEV-'408（抗 IL-15）治疗白癜风（同时也在进行 IIa 期临床试验用于乳糜泻）
追踪 FY25 营收的低位区间（$16.8-17b）
2026 年营收持平或略有下降（与 2025 年相比）
2027 财年低个位数...
与 $Royalty Pharma(RPRX)$ 达成价值 5 亿美元的协议，用于 TEV-'408（抗 IL-15）治疗白癜风（同时也在进行 IIa 期临床试验用于乳糜泻）
追踪 FY25 营收的低位区间（$16.8-17b）
2026 年营收持平或略有下降（与 2025 年相比）
2027 财年低个位数...
7讨论 · 7赞
Royalty Pharma(RPRX)
2025-12-04 06:15
$Royalty Pharma(RPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001814876-25-000009 Size: 10 KB 网页链接
Royalty Pharma(RPRX)
2025-11-25 06:35
$Royalty Pharma(RPRX)$ 144 Report of proposed sale of securities Accession Number: 0001958244-25-004476 Act: 33 Size: 9 KB 网页链接
Royalty Pharma(RPRX)
2025-12-18 06:45
$Royalty Pharma(RPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001838139-25-000010 Size: 7 KB 网页链接
Royalty Pharma(RPRX)
01-07 05:25
$Royalty Pharma(RPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001814876-26-000002 Size: 10 KB 网页链接
Royalty Pharma(RPRX)
01-27 05:15
$Royalty Pharma(RPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001838139-26-000008 Size: 7 KB 网页链接
Royalty Pharma(RPRX)
02-03 06:05
$Royalty Pharma(RPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001838139-26-000010 Size: 7 KB 网页链接
Royalty Pharma(RPRX)
02-05 06:15
$Royalty Pharma(RPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001814876-26-000006 Size: 17 KB 网页链接
Royalty Pharma(RPRX)
02-04 06:35
$Royalty Pharma(RPRX)$ 144 Report of proposed sale of securities Accession Number: 0001958244-26-000067 Act: 33 Size: 27 KB 网页链接
Royalty Pharma(RPRX)
01-07 05:25
$Royalty Pharma(RPRX)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0002096372-26-000004 Size: 300 KB 网页链接
Royalty Pharma(RPRX)
01-07 05:25
$Royalty Pharma(RPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001838139-26-000002 Size: 7 KB 网页链接
Royalty Pharma(RPRX)
01-08 06:05
$Royalty Pharma(RPRX)$ 144 Report of proposed sale of securities Accession Number: 0001958244-26-000031 Act: 33 Size: 10 KB 网页链接
Royalty Pharma(RPRX)
2025-12-16 07:25
$Royalty Pharma(RPRX)$ 144 Report of proposed sale of securities Accession Number: 0001958244-25-004546 Act: 33 Size: 15 KB 网页链接
Royalty Pharma(RPRX)
2025-11-14 00:15
$Royalty Pharma(RPRX)$ SCHEDULE 13G/A [Amend] Statement of Beneficial Ownership by Certain Investors Accession Number: 0001562230-25-000125 Act: 34 Size: 7 KB 网页链接
Royalty Pharma(RPRX)
01-03 05:15
$Royalty Pharma(RPRX)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001683607-26-000002 Size: 4 KB 网页链接
Royalty Pharma(RPRX)
01-03 07:25
$Royalty Pharma(RPRX)$ 144 Report of proposed sale of securities Accession Number: 0001958244-26-000001 Act: 33 Size: 18 KB 网页链接
Royalty Pharma(RPRX)
2025-12-17 10:45
$Royalty Pharma(RPRX)$ 144 Report of proposed sale of securities Accession Number: 0001628280-25-057480 Act: 33 Size: 7 KB 网页链接
Royalty Pharma(RPRX)
2025-11-18 06:45
$Royalty Pharma(RPRX)$ 144 Report of proposed sale of securities Accession Number: 0001958244-25-004461 Act: 33 Size: 6 KB 网页链接
Royalty Pharma(RPRX)
2025-12-02 05:55
$Royalty Pharma(RPRX)$ 144 Report of proposed sale of securities Accession Number: 0001628280-25-054475 Act: 33 Size: 4 KB 网页链接
Royalty Pharma(RPRX)
2025-12-02 06:15
$Royalty Pharma(RPRX)$ 144 Report of proposed sale of securities Accession Number: 0001964306-25-000422 Act: 33 Size: 4 KB 网页链接